Back
Biogen, Inc. Stock Price Chart
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
63
BIIB
Biogen, Inc.
Last Price:
$187.63
Seasonality Move:
-0.76%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIIB is experiencing slight selling pressure.
Biogen, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 180.87 | Buy |
| 20-day SMA: | 176.91 | Buy |
| 50-day SMA: | 170.82 | Buy |
| 200-day SMA: | 142.24 | Buy |
| 8-day EMA: | 182.3 | Buy |
| 20-day EMA: | 178.45 | Buy |
| 50-day EMA: | 170.86 | Buy |
| 200-day EMA: | 155.27 | Buy |
Biogen, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.64 | Buy |
| Relative Strength Index (14 RSI): | 68.39 | Buy |
| Chaikin Money Flow: | -553698 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (172.87 - 182.21) | Buy |
| Bollinger Bands (100): | (140.78 - 173.44) | Buy |
Biogen, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biogen, Inc. Stock
Is Biogen, Inc. Stock a Buy?
-
Biogen, Inc. share price is 187.62 while BIIB 8-day simple moving average is 180.87, which is a Buy signal.
-
The stock price of BIIB is 187.62 while Biogen, Inc. 20-day SMA is 176.91, which makes it a Buy.
-
Biogen, Inc. 50-day simple moving average is 170.82 while BIIB share price is 187.62, making it a Buy technically.
-
BIIB stock price is 187.62 and Biogen, Inc. 200-day simple moving average is 142.24, creating a Buy signal.
BIIB Technical Analysis vs Fundamental Analysis
Buy
63
Biogen, Inc. (BIIB)
is a Buy
Is Biogen, Inc. a Buy or a Sell?
-
Biogen, Inc. stock is rated a BuyThe current Biogen, Inc. [BIIB] share price is $187.62. The Score for BIIB is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Biogen, Inc. Stock Info
Market Cap:
27.5B
Price in USD:
187.62
Share Volume:
1.4M
Biogen, Inc. 52-Week Range
52-Week High:
190.20
52-Week Low:
110.04
Buy
63
Biogen, Inc. (BIIB)
is a Buy
Biogen, Inc. Share Price Forecast
-
What is the Biogen, Inc. stock price today?The Biogen, Inc. stock price is 187.62 USD today.
-
Will BIIB stock go up or go down?Biogen, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Biogen, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biogen, Inc. is not overvalued.
Is Biogen, Inc. Stock a Buy?
-
Biogen, Inc. share price is 187.62 while BIIB 8-day exponential moving average is 182.30, which is a Buy signal.
-
The stock price of BIIB is 187.62 while Biogen, Inc. 20-day EMA is 178.45, which makes it a Buy.
-
Biogen, Inc. 50-day exponential moving average is 170.86 while BIIB share price is 187.62, making it a Buy technically.
-
BIIB stock price is 187.62 and Biogen, Inc. 200-day simple moving average is 155.27, creating a Buy signal.
Fundamental Analysis of Biogen, Inc.
Is Biogen, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.77 per share.
Technical Analysis of Biogen, Inc.
Should I short Biogen, Inc. stock?
-
BIIB Moving Average Covergence Divergence (MACD) indicator is 3.64, suggesting Biogen, Inc. is a Buy
-
Biogen, Inc. Relative Strength Index (RSI) is 68.39, which suggest Biogen, Inc. is overbought
-
The Bollinger Bands (25) for Biogen, Inc. is (172.87 - 182.21), which suggest Biogen, Inc. is a Buy
-
The Bollinger Bands (100) for Biogen, Inc. is (140.78 - 173.44), which suggest Biogen, Inc. is a Buy
* Biogen, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.